Sugi Predict

Sugi Predict / Compounds / SCHEMBL13680498

SCHEMBL13680498

SCHEMBL13680498

Cc1cccc(OC(F)(F)F)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCR1 P32246 1/20 0.43
▸ CCR8 P51685 1/20 0.43
▸ IDH1 O75874 3/20 0.41
▸ IDH2 P48735 1/20 0.41
▸ NOS3 P29474 1/20 0.40
▸ NOS2 P35228 1/20 0.40
▸ RXRA P19793 3/20 0.36
▸ GRIN1 Q05586 3/20 0.36
▸ GRIN2B Q13224 3/20 0.36
▸ CYP11B1 P15538 1/20 0.35
▸ CYP11B2 P19099 1/20 0.35
▸ GABRA5 P31644 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ HSD11B1 P28845 1/20 0.34
▸ GRM5 P41594 1/20 0.34
▸ SCN9A Q15858 2/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14545220 0.81 CCR1 (0.44) CCR1CCR8NOS3NOS2RXRA
SCHEMBL20043162 0.76 IDH1 (0.37) IDH1IDH2GRM5
SCHEMBL2302960 0.75 CYP3A4 (0.42) IDH1IDH2
SCHEMBL30319918 0.75 NOS3 (0.40) IDH1IDH2NOS3NOS2RXRA
SCHEMBL2306499 0.75 HTR7 (0.43) IDH1IDH2GRM5
SCHEMBL2302655 0.75 NOS3 (0.40) IDH1IDH2NOS3NOS2RXRA
SCHEMBL20049307 0.75 IDH1 (0.38) IDH1IDH2
SCHEMBL31445247 0.75 HTR7 (0.43) IDH1IDH2GRM5
SCHEMBL16289639 0.75 IDH1 (0.38) IDH1IDH2
SCHEMBL14082025 0.75 CCR1 (0.52) CCR1CCR8NOS3NOS2GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023217879-A1 PYRROLIDIONE DERIVATIVES AS INHIBITORS OF NF KAPPA B INDUCING KINASE JANSSEN PHARMACEUTICA NV (BE) 2023-11-16 — — WO disclosed
US-20230309388-A1 ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE Beijing Summer Sprout Technology Co., Ltd. (CN) 2023-09-28 — — US disclosed
WO-2023115149-A1 BIFUNCTIONAL SULPHONAMIDE COMPOUNDS Anaxis Pharma Pty Ltd (AU) 2023-06-29 — — WO disclosed
WO-2023114198-A2 METHODS FOR THE SYNTHESIS OF COMPLEMENT FACTOR D INHIBITORS ALEXION PHARMACEUTICALS, INC. (US) 2023-06-22 — — WO disclosed
WO-2023114200-A2 METHODS FOR THE SYNTHESIS OF COMPLEMENT FACTOR D INHIBITORS AND INTERMEDIATES THEREOF ALEXION PHARMACEUTICALS, INC. (US) 2023-06-22 — — WO disclosed
WO-2023064343-A1 SMALL MOLECULE MODULATORS OF GLUCOCEREBROSIDASE ACTIVITY AND USES THEREOF VANQUA BIO, INC. (US) 2023-04-20 — — WO disclosed
WO-2021253095-A1 SULPHONAMIDE COMPOUNDS Anaxis Pharma Pty Ltd (AU) 2021-12-23 — — WO disclosed
US-11059804-B2 Protein kinase C inhibitors and methods of their use NOVARTIS AG (CH) 2021-07-13 — — US disclosed
US-20210032236-A1 NOVEL GLUTAMINASE INHIBITORS RHIZEN PHARMACEUTICALS AG (CH) 2021-02-04 — — US disclosed
EP-3092236-B1 NOVEL GLUTAMINASE INHIBITORS RHIZEN PHARMACEUTICALS S A (CH) 2020-08-26 — — EP disclosed
EP-2952096-A1 METHOD FOR CONTROLLING ARTHROPOD PEST Sumitomo Chemical Company, Limited (JP) 2015-12-09 — — EP disclosed
US-20150344466-A1 METHOD FOR CONTROLLING ARTHROPOD PEST SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-12-03 — — US disclosed
CN-104955332-A Method for controlling arthropod pest SUMITOMO CHEMICAL CO 2015-09-30 — — CN disclosed
WO-2015101957-A2 NOVEL GLUTAMINASE INHIBITORS RHIZEN PHARMACEUTICALS SA (CH) 2015-07-09 — — WO disclosed
WO-2015101958-A2 NOVEL INHIBITORS OF GLUTAMINASE RHIZEN PHARMACEUTICALS SA (CH) 2015-07-09 — — WO disclosed
US-20150005348-A1 AMIDE COMPOUND AND USE THEREOF FOR PEST CONTROL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-01-01 — — US disclosed
EP-2813492-A1 AMIDE COMPOUND AND USE THEREOF FOR PEST CONTROL Sumitomo Chemical Co., Ltd (JP) 2014-12-17 — — EP disclosed
CN-104105694-A Amide compound and use thereof for pest control SUMITOMO CHEMICAL CO 2014-10-15 — — CN disclosed
US-7582658-B2 Bicyclic compound ASAHI KASEI PHARMA CORPORATION (JP) 2009-09-01 — — US disclosed
US-7582658-B2 Bicyclic compound ASAHI KASEI PHARMA CORPORATION (JP) 2009-09-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150344466-A1 METHOD FOR CONTROLLING ARTHROPOD PEST H1-0, H1-3, H1-2 CCR1 1334/4885CCR8 1730/4885IDH1 2789/4885
US-20210032236-A1 NOVEL GLUTAMINASE INHIBITORS GLS, GLS2, GLUL CCR1 4802/4885CCR8 4817/4885IDH1 39/4885
US-20150005348-A1 AMIDE COMPOUND AND USE THEREOF FOR PEST CONTROL RPS8, MT-CO2, ARG1 CCR1 931/4885CCR8 144/4885IDH1 2992/4885
US-11059804-B2 Protein kinase C inhibitors and methods of their use PRKCA, PRKCB, PRKCH CCR1 3873/4885CCR8 3630/4885IDH1 3687/4885
US-20230309388-A1 ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE OCIAD1, OCIAD2, SLCO4C1 CCR1 928/4885CCR8 2057/4885IDH1 519/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.